MultiMab therapy (Meristem/Shantha West)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameMultiMab therapy (Meristem/Shantha West)
Drug Alias NameAgRM-1PMAb1PMAb3AgRM-2PMAb2 +[10] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesShantha West Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShantha West IncMeristem Therapeutics
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A